Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
30
FSPKF Quote, Financials, Valuation and Earnings
Last price:
$22.10
Seasonality move
:
2.13%
Day range:
$22.10 - $22.10
52-week range:
$16.35 - $25.69
Dividend yield:
1.59%
P/E ratio:
51.00x
P/S ratio:
10.22x
P/B ratio:
116.82x
Volume:
--
Avg. volume:
2.2K
1-year change:
-2.17%
Market cap:
$13B
Revenue:
$1.2B
EPS (TTM):
$0.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
-- | -- | -- | -- | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$298.6M | $0.20 | 13.44% | 28.72% | $31.21 |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -- | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$22.10 | -- | $13B | 51.00x | $0.17 | 1.59% | 10.22x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$23.99 | $31.21 | $4.1B | 15.44x | $0.00 | 0% | 3.86x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
PFGTF
Pacific Edge Ltd.
|
$0.23 | -- | $237.9M | -- | $0.00 | 0% | 19.89x |
|
RHCGF
Ryman Healthcare Ltd.
|
$1.41 | -- | $705M | -- | $0.00 | 0% | 2.72x |
|
SMGRF
Summerset Group Holdings Ltd.
|
$6.97 | -- | $1.7B | 7.89x | $0.07 | 2.02% | 8.25x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
3.28% | 1.642 | -- | 1.14x |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
5.64% | 2.900 | 1.52% | 2.70x |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
PFGTF
Pacific Edge Ltd.
|
1.14% | -4.632 | -- | 2.82x |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | 2.214 | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
36.6% | -0.062 | -- | 0.11x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FSPKF
Fisher & Paykel Healthcare Corp. Ltd.
|
$299.7M | -$209.7M | 18.6% | 19.71% | 40.18% | -- |
|
ACAD
ACADIA Pharmaceuticals, Inc.
|
$257M | $35.8M | 31.98% | 34.23% | 12.83% | $73.9M |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge Ltd.
|
-- | -- | -69.68% | -72.02% | -- | -- |
|
RHCGF
Ryman Healthcare Ltd.
|
-- | -- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings Ltd.
|
-- | -- | 5.8% | 12.83% | -- | -- |
Fisher & Paykel Healthcare Corp. Ltd. vs. Competitors
-
Which has Higher Returns FSPKF or ACAD?
ACADIA Pharmaceuticals, Inc. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of 25.76%. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat ACADIA Pharmaceuticals, Inc.'s return on equity of 34.23%.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B ACADACADIA Pharmaceuticals, Inc.92.23% $0.42 $972.1M -
What do Analysts Say About FSPKF or ACAD?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand ACADIA Pharmaceuticals, Inc. has an analysts' consensus of $31.21 which suggests that it could grow by 30.1%. Given that ACADIA Pharmaceuticals, Inc. has higher upside potential than Fisher & Paykel Healthcare Corp. Ltd., analysts believe ACADIA Pharmaceuticals, Inc. is more attractive than Fisher & Paykel Healthcare Corp. Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 ACADACADIA Pharmaceuticals, Inc.9 6 1 -
Is FSPKF or ACAD More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, which suggesting that the stock is 23.67% more volatile than S&P 500. In comparison ACADIA Pharmaceuticals, Inc. has a beta of 0.660, suggesting its less volatile than the S&P 500 by 33.951%.
-
Which is a Better Dividend Stock FSPKF or ACAD?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.59%. ACADIA Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. ACADIA Pharmaceuticals, Inc. pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or ACAD?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than ACADIA Pharmaceuticals, Inc. quarterly revenues of $278.6M. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than ACADIA Pharmaceuticals, Inc.'s net income of $71.8M. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 51.00x while ACADIA Pharmaceuticals, Inc.'s PE ratio is 15.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 10.22x versus 3.86x for ACADIA Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M ACADACADIA Pharmaceuticals, Inc.3.86x 15.44x $278.6M $71.8M
-
Which has Higher Returns FSPKF or AROAF?
Aroa Biosurgery has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About FSPKF or AROAF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Aroa Biosurgery, analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 AROAFAroa Biosurgery0 0 0 -
Is FSPKF or AROAF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, which suggesting that the stock is 23.67% more volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock FSPKF or AROAF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.59%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or AROAF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Aroa Biosurgery quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Aroa Biosurgery's net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 51.00x while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 10.22x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns FSPKF or PFGTF?
Pacific Edge Ltd. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Pacific Edge Ltd.'s return on equity of -72.02%.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B PFGTFPacific Edge Ltd.-- -- $15.1M -
What do Analysts Say About FSPKF or PFGTF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Pacific Edge Ltd., analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Pacific Edge Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 PFGTFPacific Edge Ltd.0 0 0 -
Is FSPKF or PFGTF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, which suggesting that the stock is 23.67% more volatile than S&P 500. In comparison Pacific Edge Ltd. has a beta of -3.385, suggesting its less volatile than the S&P 500 by 438.481%.
-
Which is a Better Dividend Stock FSPKF or PFGTF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.59%. Pacific Edge Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Pacific Edge Ltd. pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or PFGTF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Pacific Edge Ltd. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Pacific Edge Ltd.'s net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 51.00x while Pacific Edge Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 10.22x versus 19.89x for Pacific Edge Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M PFGTFPacific Edge Ltd.19.89x -- -- --
-
Which has Higher Returns FSPKF or RHCGF?
Ryman Healthcare Ltd. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Ryman Healthcare Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B RHCGFRyman Healthcare Ltd.-- -- -- -
What do Analysts Say About FSPKF or RHCGF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Ryman Healthcare Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Ryman Healthcare Ltd., analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Ryman Healthcare Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 RHCGFRyman Healthcare Ltd.0 0 0 -
Is FSPKF or RHCGF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, which suggesting that the stock is 23.67% more volatile than S&P 500. In comparison Ryman Healthcare Ltd. has a beta of 0.513, suggesting its less volatile than the S&P 500 by 48.743%.
-
Which is a Better Dividend Stock FSPKF or RHCGF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.59%. Ryman Healthcare Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Ryman Healthcare Ltd. pays out -- of its earnings as a dividend. Fisher & Paykel Healthcare Corp. Ltd.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or RHCGF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Ryman Healthcare Ltd. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Ryman Healthcare Ltd.'s net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 51.00x while Ryman Healthcare Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 10.22x versus 2.72x for Ryman Healthcare Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M RHCGFRyman Healthcare Ltd.2.72x -- -- --
-
Which has Higher Returns FSPKF or SMGRF?
Summerset Group Holdings Ltd. has a net margin of 29.46% compared to Fisher & Paykel Healthcare Corp. Ltd.'s net margin of --. Fisher & Paykel Healthcare Corp. Ltd.'s return on equity of 19.71% beat Summerset Group Holdings Ltd.'s return on equity of 12.83%.
Company Gross Margin Earnings Per Share Invested Capital FSPKFFisher & Paykel Healthcare Corp. Ltd.41.41% $0.36 $1.1B SMGRFSummerset Group Holdings Ltd.-- -- $2.6B -
What do Analysts Say About FSPKF or SMGRF?
Fisher & Paykel Healthcare Corp. Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Summerset Group Holdings Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fisher & Paykel Healthcare Corp. Ltd. has higher upside potential than Summerset Group Holdings Ltd., analysts believe Fisher & Paykel Healthcare Corp. Ltd. is more attractive than Summerset Group Holdings Ltd..
Company Buy Ratings Hold Ratings Sell Ratings FSPKFFisher & Paykel Healthcare Corp. Ltd.0 0 0 SMGRFSummerset Group Holdings Ltd.0 0 0 -
Is FSPKF or SMGRF More Risky?
Fisher & Paykel Healthcare Corp. Ltd. has a beta of 1.237, which suggesting that the stock is 23.67% more volatile than S&P 500. In comparison Summerset Group Holdings Ltd. has a beta of -0.179, suggesting its less volatile than the S&P 500 by 117.891%.
-
Which is a Better Dividend Stock FSPKF or SMGRF?
Fisher & Paykel Healthcare Corp. Ltd. has a quarterly dividend of $0.17 per share corresponding to a yield of 1.59%. Summerset Group Holdings Ltd. offers a yield of 2.02% to investors and pays a quarterly dividend of $0.07 per share. Fisher & Paykel Healthcare Corp. Ltd. pays 77.61% of its earnings as a dividend. Summerset Group Holdings Ltd. pays out 16.94% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios FSPKF or SMGRF?
Fisher & Paykel Healthcare Corp. Ltd. quarterly revenues are $723.8M, which are larger than Summerset Group Holdings Ltd. quarterly revenues of --. Fisher & Paykel Healthcare Corp. Ltd.'s net income of $213.2M is higher than Summerset Group Holdings Ltd.'s net income of --. Notably, Fisher & Paykel Healthcare Corp. Ltd.'s price-to-earnings ratio is 51.00x while Summerset Group Holdings Ltd.'s PE ratio is 7.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fisher & Paykel Healthcare Corp. Ltd. is 10.22x versus 8.25x for Summerset Group Holdings Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FSPKFFisher & Paykel Healthcare Corp. Ltd.10.22x 51.00x $723.8M $213.2M SMGRFSummerset Group Holdings Ltd.8.25x 7.89x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
